相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genotyping and Genomic Profiling of Non-Small-Cell Lung Cancer: Implications for Current and Future Therapies
Tianhong Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
New Targetable Oncogenes in Non-Small-Cell Lung Cancer
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Treatment of Triple-Negative Breast Cancer Using Anti-EGFR-Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor
Fares Al-Ejeh et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells
Hsiao-Ching Chuang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The role of PARP in DNA repair and its therapeutic exploitation
M. Javle et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody
Greta Garrido et al.
JOURNAL OF IMMUNOLOGY (2011)
Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft
Joana M. Senra et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice
Majid Ali et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The RNA-binding protein La contributes to cell proliferation and CCND1 expression
G. Sommer et al.
ONCOGENE (2011)
Implication of RNA-Binding Protein La in Proliferation, Migration and Invasion of Lymph Node-Metastasized Hypopharyngeal SCC Cells
Gunhild Sommer et al.
PLOS ONE (2011)
Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Hong Song et al.
CURRENT DRUG DELIVERY (2011)
Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
F. Al-Ejeh et al.
ONCOGENE (2010)
Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
Jun Hou et al.
PLOS ONE (2010)
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
Majid Ali et al.
CLINICAL CANCER RESEARCH (2009)
A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution
Fares Al-Ejeh et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy
Fares Al-Ejeh et al.
PLOS ONE (2009)
Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors
Fares Al-Ejeh et al.
PLOS ONE (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden et al.
NATURE MEDICINE (2008)
Cross-fire doses from β-emitting radionuclides in targeted radiotherapy.: A theoretical study based on experimentally measured tumor characteristics
S. A. Enger et al.
PHYSICS IN MEDICINE AND BIOLOGY (2008)
Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival
Maria Teresa Landi et al.
PLOS ONE (2008)
The la autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugs
Fares Al-Ejeh et al.
CLINICAL CANCER RESEARCH (2007)
In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the la autoantigen
Fares Al-Ejeh et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
Jeffrey M. Albert et al.
CLINICAL CANCER RESEARCH (2007)
Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen
YV Kovtun et al.
CANCER RESEARCH (2006)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361
CR Calabrese et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
BCR/ABL activates mdm2 rnRNA translation via the La antigen
R Trotta et al.
CANCER CELL (2003)
分享论文
